Epicast Report: Psoriasis - Epidemiology Forecast to 2024 Key Trends, Size, Growth, Shares and Forecast

Submitted by: Submitted by

Views: 10

Words: 938

Pages: 4

Category: Business and Industry

Date Submitted: 11/24/2015 11:33 PM

Report This Essay

Researchmoz added Most up-to-date research on "EpiCast Report: Psoriasis - Epidemiology Forecast to 2024" to its huge collection of research reports.

Psoriasis is a chronic, immune-mediated inflammatory skin disease. Psoriasis ranges in severity from a few scattered, sharply demarcated, scaly, red, coin-sized skin lesions or scaly plaques to involvement of almost the entire body surface. Psoriasis is more prevalent in colder areas, and less prevalent in the tropics and warmer regions of the world. Globally, the one-year prevalence of psoriasis varies with the differences in prevalence of psoriasis attributed to variations in environmental factors, genetic factors, and differences in the case definition used to diagnose psoriasis in epidemiology studies.

To Get Sample Copy of Report visit @ http://www.researchmoz.us/enquiry.php?type=S&repid=466519

GlobalData epidemiologists forecast an increase in the one-year diagnosed prevalent cases of psoriasis in the 8MM, from 43,747,201 cases in 2014 to 50,455,013 cases in 2024, with an Annual Growth Rate (AGR) of 1.53% during the forecast period. In 2024, India will have the highest number of one-year diagnosed prevalent cases of psoriasis in the 8MM, with 32,853,676 cases, whereas Japan will have the lowest number of one-year diagnosed prevalent cases of psoriasis, with 482,431 cases in 2024.

This report provides an overview of the risk factors, comorbidities, and the global and historical trends for psoriasis in the eight major markets (8MM) (US, France, Germany, Italy, Spain, UK, Japan, and India). The report also provides a 10-year epidemiological forecast of the one-year diagnosed prevalent cases of psoriasis segmented by sex, age (at 10-year intervals, starting at age zero years and ending at ages =80 years), and severity (mild, moderate, and severe) in the 8MM.

Scope

- The Psoriasis EpiCast Report provides an overview of the risk factors, comorbidities, and the global and historical trends for...